FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

STAT PROFILE ULTRA L ANALYZER QUALITY CONTROL MATERIALS

K Number: K961938 · Decision Jun 28, 1996
Classifications
1
FEI Numbers
31
Registration Numbers
31
Same Product Code
126
Applicant Total
89
Review Days
39

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
STAT PROFILE ULTRA L ANALYZER QUALITY CONTROL MATERIALS
K Number
K961938
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
864.7750
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Nova Biomedical Corp.
Date Received
May 20, 1996
Decision Date
June 28, 1996
Product Code
GJS
Advisory Committee
Hematology
Review Advisory Committee
HE
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GJS Test, Time, Prothrombin

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (GJS), ordered by most recent decision date.

View all

Other Clearances by Nova Biomedical Corp.

K Number Device Name
K100602 NOVA STATSTRIP LACTATE HOSPITAL METER, NOVA STATSTRIP LACTATE TEST STRIPS
K101633 NOVA MAX PLUS GLOCOSE AND B-KETONE CONTROL SOLUTION-MID, HIGH
K091547 NOVA MAX PLUS BLOOD GLUCOSE AND B-KETONE MONITOR SYSTEM, NOVA MAX PLUS B-KETONE CONTROL SOLUTIONS, NOVA MAX BLOOD GLUCOS
K070960 NOVA STATSTRIP XPRESS GLUCOSE HOSPITAL METER SYSTEM
K070255 NOVA MAX BLOOD GLUCOSE MONITOR SYSTEM, 90001,90002
K070068 NOVA STATSENSOR CREATININE HOSPITAL METER, CONTROL SOLUTIONS,LINEARITY SOLUTIONS, AND TEST STRIPS
K063821 NOVA STATSTRIP GLUCOSE HOSPITAL METER SYSTEM
K061830 STAT PROFILE CRITICAL CARE XPRESS (CCX), MODEL 1+
K060345 NOVA STATSTRIP GLUCOSE HOSPITAL METER, STATSTRIP CONTROL SOLUTIONS
K041016 NOVA GLUCOSE LOW/HIGH LEVEL CONTROL SOLUTIONS
Search all 89 clearances from Nova Biomedical Corp. →